BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33999068)

  • 1. Circumventing paclitaxel resistance in breast cancer cells using a nanoemulsion system and determining its efficacy via an impedance biosensor.
    Attari F; Hazim H; Zandi A; Mazarei Z; Rafati H
    Analyst; 2021 May; 146(10):3225-3233. PubMed ID: 33999068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.
    Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y
    Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response.
    Pawar VK; Panchal SB; Singh Y; Meher JG; Sharma K; Singh P; Bora HK; Singh A; Datta D; Chourasia MK
    J Control Release; 2014 Dec; 196():295-306. PubMed ID: 25459427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.
    Sootichote R; Thuwajit P; Singsuksawat E; Warnnissorn M; Yenchitsomanus PT; Ithimakin S; Chantharasamee J; Thuwajit C
    BMC Cancer; 2018 Feb; 18(1):231. PubMed ID: 29486738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells.
    Jeansonne DP; Koh GY; Zhang F; Kirk-Ballard H; Wolff L; Liu D; Eilertsen K; Liu Z
    Oncol Rep; 2011 May; 25(5):1473-80. PubMed ID: 21331447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
    Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
    Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel taxane, difluorovinyl-ortataxel, effectively overcomes paclitaxel-resistance in breast cancer cells.
    Rong D; Wang C; Zhang X; Wei Y; Zhang M; Liu D; Farhan H; Momen Ali SA; Liu Y; Taouil A; Guo W; Wang Y; Ojima I; Yang S; Wang H
    Cancer Lett; 2020 Oct; 491():36-49. PubMed ID: 32730778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-Loaded Colloidal Silica and TPGS-Based Solid Self-Emulsifying System Interferes Akt/mTOR Pathway in MDA-MB-231 and Demonstrates Anti-tumor Effect in Syngeneic Mammary Tumors.
    Meher JG; Dixit S; Singh Y; Pawar VK; Konwar R; Saklani R; Chourasia MK
    AAPS PharmSciTech; 2020 Nov; 21(8):313. PubMed ID: 33165766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced apoptosis and mitochondrial cell death by paclitaxel-loaded TPP-TPGS
    Yadav PK; Saklani R; Tiwari AK; Verma S; Rana R; Chauhan D; Yadav P; Mishra K; Kedar AS; Kalleti N; Gayen JR; Wahajuddin M; Rath SK; Mugale MN; Mitra K; Sharma D; Chourasia MK
    Nanomedicine (Lond); 2023 Feb; 18(4):343-366. PubMed ID: 37140535
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis.
    Zou H; Li L; Garcia Carcedo I; Xu ZP; Monteiro M; Gu W
    Int J Nanomedicine; 2016; 11():1947-58. PubMed ID: 27226714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity.
    Monteiro LOF; Fernandes RS; Castro L; Reis D; Cassali GD; Evangelista F; Loures C; Sabino AP; Cardoso V; Oliveira MC; Branco de Barros A; Leite EA
    Mol Pharm; 2019 Aug; 16(8):3477-3488. PubMed ID: 31257891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow Sulfide Donor GYY4137 Increased the Sensitivity of Two Breast Cancer Cell Lines to Paclitaxel by Different Mechanisms.
    Liskova V; Chovancova B; Galvankova K; Klena L; Matyasova K; Babula P; Grman M; Rezuchova I; Bartosova M; Krizanova O
    Biomolecules; 2024 May; 14(6):. PubMed ID: 38927055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of paclitaxel and verapamil to overcome multi-drug resistance in breast cancer cells.
    Li P; Zhong D; Gong PY
    Biochem Biophys Res Commun; 2019 Aug; 516(1):183-188. PubMed ID: 31204050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereocomplex micelle loaded with paclitaxel for enhanced therapy of breast cancer in an orthotopic mouse model.
    Piao L; Li Y; Zhang H; Jiang J
    J Biomater Sci Polym Ed; 2019 Feb; 30(3):233-246. PubMed ID: 30606090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratiometric codelivery of Paclitaxel and Baicalein loaded nanoemulsion for enhancement of breast cancer treatment.
    Yadav PK; Saklani R; Tiwari AK; Verma S; Chauhan D; Yadav P; Rana R; Kalleti N; Gayen JR; Wahajuddin ; Rath SK; Mugale MN; Mitra K; Chourasia MK
    Int J Pharm; 2023 Aug; 643():123209. PubMed ID: 37422142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism.
    Bashmail HA; Alamoudi AA; Noorwali A; Hegazy GA; Ajabnoor GM; Al-Abd AM
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31968657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-18a upregulation decreases Dicer expression and confers paclitaxel resistance in triple negative breast cancer.
    Sha LY; Zhang Y; Wang W; Sui X; Liu SK; Wang T; Zhang H
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2201-8. PubMed ID: 27338043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations.
    Desai A; Vyas T; Amiji M
    J Pharm Sci; 2008 Jul; 97(7):2745-56. PubMed ID: 17854074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone simulates the anticancer effect of nano-formulated paclitaxel in breast cancer cells.
    Diab T; AlKafaas SS; Shalaby TI; Hessien M
    Bioorg Chem; 2020 Jun; 99():103792. PubMed ID: 32240873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.